Financial Performance - Revenue remained flat year-over-year at RMB6644 million[9,46] - Adjusted net profit decreased by 61% year-over-year to RMB1022 million, attributed to pricing decreases and marketing expenses[9,46] - Overseas sales increased by 40% year-over-year, reaching RMB1624 million, representing 244% of total sales[11,46] - R&D expenses reached RMB320 million, accounting for 47% of revenue[11] Business Segments - General medical device segment revenue was RMB3300 million, flat year-over-year, with a profit of RMB490 million, down by 171%[16] - Pharma packaging segment revenue was RMB1170 million, flat year-over-year, with a profit of RMB450 million, down by 58%[24] - Orthopaedics segment revenue was RMB730 million, slightly down by 16% year-over-year, but profit increased significantly by 743% to RMB150 million[27] - Blood management segment revenue increased by 81% year-over-year to RMB450 million, while profit decreased by 53% to RMB31 million[37] Strategic Initiatives - The company plans to maintain a dividend payout ratio at 50%[52] - Total production capacity for blood bags is expected to exceed 100 million units in 2025[37] - Auto injectors recorded strong sales in China, with H1 sales up by approximately 200%, accounting for approximately 3% of segment sales[24]

Financial Performance - Core profit reached RMB 3.22 billion, with domestic businesses contributing RMB 3.1 billion, a year-over-year increase of 0.7%[3] - Retail gas sales volume increased by 1.9% year-over-year to 12.95 billion m3[3] - Gross profit of the IE business increased by 2.1% year-over-year to RMB 1.09 billion[3] - Gross profit of the smart home business increased by 4.9% year-over-year to RMB 1.47 billion[3] - Revenue increased by 2.0% to RMB 55.673 billion[6] - Profit attributable to shareholders decreased by 5.6% to RMB 2.429 billion[6] Business Development - Newly installed designed daily capacity for C/I customers reached 6.29 million m3, and 692,000 residential household customers were newly developed[3] - Installed capacity of photovoltaic increased by 231% year-over-year to 324.5 MW[3] - Contracted value of intelligent products in the smart home business increased by 81% year-over-year to RMB 553 million[3] Strategic Initiatives - The company is focusing on customer needs and upgrading products and services to increase contributions from integrated energy and smart home businesses[5] - The company is actively promoting the integrated energy concept and accelerating PV and energy storage deployment[12] - The company is identifying customer needs in security services and creating an integrated model for value-added services in the smart home business[14] Dividend - The company declares an interim dividend of HK$0.65 per share[3]

Innovent Biologics 2025 Interim Results Advancing toward a New Era of Growth and Global Innovation August 2025 Agenda and Speakers | Business Review and Outlook | Dr. Michael Yu | Founder, Chairman of the Board, CEO | | --- | --- | --- | | R&D Highlight Updates | Dr. Hui Zhou Dr. Lei Qian | Chief R&D Officer, Oncology Chief R&D Officer, General Biomedicine | | Financials and Summary | Ms. Rachel You | Chief Financial Officer | | Q&A | Management Team | | Confidential Copyright© 2025 Innovent 2025H1: Continu ...

Financial Performance - The Group's revenue reached RMB 500.1 billion, a 1.0% year-over-year increase[11] - OPAT (Operating Profit After Tax) grew by 3.7% year-over-year to RMB 77.7 billion[13] - Shareholders' equity increased by 1.7% YTD (Year-to-Date) after dividend distribution, reaching RMB 944 billion[13] - Interim dividend per share (DPS) increased by 2.2% year-over-year to RMB 0.95[13] - NBV (New Business Value) for Life & Health (L&H) grew significantly by 39.8% year-over-year[15] Business Segments - P&C (Property & Casualty) premium income increased by 7.1% year-over-year to RMB 171.9 billion[15] - P&C insurance revenue grew by 2.3% year-over-year to RMB 165.7 billion[15] - The P&C Combined Operating Ratio (COR) improved by 2.6 percentage points year-over-year to 95.2%[15] - Bank net profit amounted to RMB 24.9 billion with a NPL ratio of 1.05%[16] Customer Engagement - Retail customers increased by 1.8% YTD to 247 million[13] - 26.6% of retail customers hold 4+ contracts, with a 97.8% retention rate[13] Investment - Unannualized comprehensive investment yield was 3.1%, up 0.3 percentage points year-over-year[16] - Insurance funds grew 8.2% YTD to RMB 6.2 trillion[25]

2025 Interim Results Investor Presentation August 2025 Contents 1. Results Highlights 5. ESG Development 2. Scale & Profitability Strengths 6. Outlook 3. Financial Stability Strengths 7. Appendices 4. Competitive Development Strengths Beijing | Corniche 1. Results Highlights 2025 Interim Results Highlights Sales remained among the top in the industry Contracted sales 120.15b Leading sales scale in first-tier cities Contracted sales in Hong Kong, Beijing, Shanghai, Guangzhou and Shenzhen 55.64b Leading marke ...

Disclaimer The information contained in this presentation is intended solely for your personal reference. In addition, such information contains projections and forward-looking statements that rellect the Company's current views with respect to future events and financial performance. These views are based on assumptions subject to various risks. No assurance can be given that future events will occur, that projections will be achieved, or that the Company's assumptions are correct. Actual results may diffe ...

Financial Performance - The company's underlying profit decreased by 1% year-over-year to HK$5,118 million[13, 15] - Net profit attributable to shareholders decreased by 8.7% year-over-year to HK$4,019 million[13, 15, 16] - Underlying earnings per share (EPS) decreased by 4.9% year-over-year to HK$0.58[13, 15] - Revenue decreased by 6.6% year-over-year to HK$8,183 million, mainly due to a HK$668 million reduction in property sales[15] - Net cash increased by HK$3,876 million year-over-year, reaching HK$49,461 million[13, 19] Segment Performance - Property sales profit contribution increased by 28.4% to HK$1,030 million, driven by an enhancement in segment gross profit margin[17] - Property rental profit contribution decreased by 4.4% to HK$2,799 million due to the full-year effect of the discontinuation of waiver fee concession[17] - Hotel operations profit contribution decreased by 2.5% to HK$475 million, impacted by downward pressure on room rates in Hong Kong and Singapore[17] Land Bank and Property Sales - The company has an attributable land bank of 18.9 million square feet as of June 30, 2025[22] - Property sales recognized in the financial year increased by 21.6% to HK$10,813 million, with a gross profit margin of 9.4%[37] - Total attributable contracted sales of over HK$4 billion have not yet been recognized[39] Property Rental and Investment Properties - Overall occupancy rate slightly decreased to 89.6%[53] - Revaluation loss on investment properties (net of deferred taxation) was HK$1,084 million[16, 65] - Total attributable value of investment properties increased by 0.9% to HK$89,137 million[65]

Financial Performance Highlights - The Group's insurance revenue reached RMB 280250 million, a 71% increase[101] - Net profit attributable to equity holders of the company increased by 140% to RMB 26671 million[19,101] - The Group's total investment yield (annualized) was 50%, up 09 percentage points[22,101] - Group consolidated net assets increased by 63% to RMB 3906 billion[20,41] Business Segment Performance - PICC P&C's insurance revenue grew by 56% to RMB 249040 million, with a combined ratio of 948%[57,101] - PICC Life's insurance revenue increased significantly by 325% to RMB 14018 million[68,101] - PICC Health saw a 132% rise in insurance revenue, reaching RMB 15603 million[74,101] Strategic Focus and Initiatives - The group premiums income increased by 64% to RMB 4546 billion[26] - Total insurance investment assets grew by 72% to RMB 17607 billion[32] - Business synergy generated RMB 16 billion in premiums income, an 89% increase[37] - The company is focused on strengthening core functions, promoting "Six Reforms," high-quality development, and risk prevention in the second half of 2025[90,91,92,93]

August 2025 2025 FIRST HALF RESULTS REVIEW O U R B U S I N E S S 2025 First Half Results Review ~ Stock Code: 0270 F I N A N C I A L H I G H L I G H T S 1 The unaudited consolidated profit attributable to owners of the Company for 1H25 increased by 11.2% to HK$2,682 million and interim dividend per share increased by 11.2% to HK$26.66 cents. 2 The net finance costs from continuing operations was decreased by HK$201 million to HK$188 million and net loss arising from fair value adjustments for investment pro ...

BOARD AND MANAGEMENT INTERIM RESULTS PRESENTATION AUGUST 27, 2025 DISCLAIMER This presentation contains forward-looking statements that involve risks and uncertainties. These statements are generally indicated by the use of forward-looking terminology such as "believe", "expect", "anticipate", "estimate", "plan", "project", "target", "may", "will" or other similar words that express an indication of actions or results of actions that may or are expected to occur in the future. You should not place undue rel ...